Point-of-Injury Diagnostics to Improve Millions of Lives

Beyond

COVID-19

NanoDxTM is conducting diagnostics research on a wide range of applications including traumatic brain injury, sepsis and stroke. Combined with COVID-19, these diseases affect more than 615 million people around the world each year.

  1. Based on U.S. COVID-19 test data per capita.
  2. “CENTER-TBI Fact Sheets & Policy Brief”, www.center-tbi.eu.
  3. Fact Sheets, World Health Organization, 2018, https://www.who.int/news-room/fact-sheets/detail/sepsis
  4. Global, Regional & National Burden of Stroke, 1990-2016, The Lancet Neurology, 2019.